002100.SHE Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd
- Market cap
- CNY 11.0B
- P/E
- -
- P/B
- 1.62x
- ROE
- -12.5%
- Dividend yield
- 4.02%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002100.SHE undervalued?
Graham numberThe Graham number of Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd fundamental analysis
No fundamental analysis for Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd yet.
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd
TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the feed processing, pig and poultry breeding, slaughtering and meat processing, animal vaccine production, cottonseed processing, corn storage, and agricultural and livestock guarantees in China and internationally. It offers inactivated vaccines against foot-and-mouth disease, a series of vaccines for ruminants and pigs, avian influenza vaccines, and animal disease diagnostic reagents; edible cottonseed oil a…
Full company profileXinjiang Tecon Animal Husbandry Bio-Technology Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.44B | 4.63B | 5.27B | 7.48B | 12.0B | 15.7B | 17.0B | 19.0B | 17.2B | 17.0B | 17.1B |
| Gross Profit | 1.09B | 1.08B | 1.11B | 1.88B | 3.39B | 1.12B | 1.61B | 61.3M | 2.07B | 1.67B | 332M |
| Operating Income | 381M | 426M | 333M | 591M | 1.81B | -617M | 257M | -1.45B | 631M | 603M | -663M |
| EBITDA | 588M | 629M | 598M | 1.06B | 2.42B | 251M | 1.09B | -483M | 1.52B | 1.32B | -731M |
| Net Income | 393M | 407M | 314M | 644M | 1.72B | -703M | 281M | -1.36B | 605M | 211M | -795M |
| EPS | 0.41 | 0.42 | 0.33 | 0.61 | 1.60 | -0.64 | 0.21 | -1.01 | 0.44 | 0.15 | -0.58 |
| Balance Sheet | |||||||||||
| Total Assets | 4.49B | 5.87B | 8.51B | 11.2B | 15.7B | 17.2B | 19.4B | 16.8B | 17.6B | 17.4B | 20.1B |
| Total Liabilities | 1.79B | 2.82B | 5.23B | 5.99B | 8.86B | 9.40B | 9.70B | 8.84B | 9.04B | 8.85B | 11.5B |
| Shareholders' Equity | 2.63B | 2.99B | 3.21B | 4.59B | 6.23B | 7.15B | 7.95B | 6.41B | 7.02B | 6.94B | 6.38B |
| Cash & Short-term Investments | 848M | 1.81B | 2.15B | 2.09B | 2.09B | 3.42B | 3.97B | 2.82B | 3.11B | 2.08B | 2.76B |
| Total Debt | 840M | 1.77B | 4.25B | 4.69B | 6.49B | 7.10B | 7.38B | 4.91B | 5.61B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 316M | 649M | -1.18B | 307M | -601M | 1.53B | 328M | 1.75B | 1.16B | 381M | - |
| Capital Expenditure | 280M | 585M | 593M | 1.35B | 930M | 1.75B | 1.43B | 1.00B | 626M | 379M | 378M |
| Free Cash Flow | 35.8M | 64.2M | -1.77B | -1.05B | -1.53B | -219M | -1.10B | 750M | 535M | 1.91M | 158M |
| Ratios | |||||||||||
| ROE | 14.9% | 13.6% | 9.8% | 14.0% | 27.6% | -9.8% | 3.5% | -21.3% | 8.6% | 3.0% | -12.5% |
| ROA | 8.7% | 6.9% | 3.7% | 5.8% | 10.9% | -4.1% | 1.5% | -8.1% | 3.4% | 1.2% | -4.0% |
| Net Profit Margin | 8.8% | 8.8% | 5.9% | 8.6% | 14.4% | -4.5% | 1.7% | -7.2% | 3.5% | 1.2% | -4.7% |
| Debt to Equity | 0.32x | 0.59x | 1.32x | 1.02x | 1.04x | 0.99x | 0.93x | 0.77x | 0.80x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd dividends
- Dividend yield
- 4.02%
- Forward dividend
- 0.08 CNY
- Payout ratio
- 210.1%
- Ex-dividend date
- Jun 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 443M | 0.32 | 210.1% |
| 2024 | CNY 173M | 0.13 | 28.6% |
| 2023 | CNY 520M | 0.39 | - |
| 2022 | CNY 261M | 0.19 | 92.9% |
| 2021 | CNY 495M | 0.45 | - |
| 2020 | CNY 212M | 0.20 | 12.3% |
| 2019 | CNY 99.9M | 0.09 | 15.5% |
| 2018 | CNY 152M | 0.16 | 48.4% |
| 2017 | CNY 127M | 0.13 | 31.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on May 20, 2015.
Who owns Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd
- Insiders 36.79%
- Institutions 14.28%
- Public & others 48.93%
- Shares outstanding 1.37B
- Free float 867M
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd company profile
- Company name
- Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd
- Ticker
- 002100.SHE
- ISIN
- CNE000001PZ9
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Dec 26, 2006
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 4,803
- Fiscal year end
- December
- Address
- Tiankang Enterprise Building, Urumqi, China, 830011
- Phone
- 86 99 1667 9236
- Website
- tcsw.com.cn
About Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd
TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the feed processing, pig and poultry breeding, slaughtering and meat processing, animal vaccine production, cottonseed processing, corn storage, and agricultural and livestock guarantees in China and internationally. It offers inactivated vaccines against foot-and-mouth disease, a series of vaccines for ruminants and pigs, avian influenza vaccines, and animal disease diagnostic reagents; edible cottonseed oil and high-end dephenolized cottonseed protein products; and feed products, including pig, poultry, dairy cow, ruminant, aquatic, and premixed feed, as well as additives. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is headquartered in Urumqi, China.
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd management
10- Mr. Heng XuGM & Director · born 1974
- Mr. Yubin HeLegal Director & Compliance Officer · born 1969
- Ms. Yaxuan HuangHuman Resources Director · born 1975
- Mr. Xiaowen LuoAudit Director · born 1969
- Mr. Haibin HuangDeputy GM & Director · born 1968
- Mr. Yunjiang Guo CPADeputy General Manager · born 1970
- Mr. Xiao WangChief Accountant · born 1985
- Xiao Yan DuanAccounting Supervisor
- Mr. Zhenjiang YuBoard Secretary · born 1989
- Mr. Junming LiDeputy General Manager · born 1975